Matercell
MaterCell is Argentina's first private umbilical cord blood and tissue stem cell bank, founded in 2009 and based in Buenos Aires. It serves expectant families with blood and tissue cryopreservation under two plans, recurring annual storage fees, and ISO 9001/AABB-certified quality standards.
- Company typePrivate
- Founded2009
- HeadquartersBuenos Aires, Argentina
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Matercell does
MaterCell S.A. is an Argentine private company that operates the country's first private umbilical cord blood and tissue stem cell bank, founded in November 2009 and headquartered in Buenos Aires. The company collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from cord tissue, storing samples at -196°C in liquid nitrogen using AirLiquide cryopreservation systems equipped with remote monitoring and digital automation. It serves expectant families in Argentina through two service tiers: Plan 2 (Doble Cuidado), which includes blood and tissue preservation, and Plan 3 (Máxima Protección), the premium tier that adds mesenchymal cell expansion for immediate therapeutic availability. All plans include annual storage fees, viability testing, and professional medical advisory.
The company generates revenue through a hybrid model combining one-time fees for collection, processing, and initial cryopreservation with recurring annual subscription fees for ongoing storage and sample maintenance. MaterCell sells directly to consumers via phone, WhatsApp, and its website, and operates a referral channel through partnerships with hospitals and sanatoriums (Sanatorio Otamendi, Mater Dei, Hospital Italiano Regional del Sur), health insurers (Medifé, OsdePYM, Medicus, Life Seguros), and corporate employee benefit programs (Accenture, Globant, Cervecería y Maltería Quilmes). The company holds ISO 9001:2015 certification from Bureau Veritas and complies with AABB Standards for Cellular Therapy Services, and offers a USD 30,000 quality guarantee. MaterCell also operates MaterCare, a complementary educational platform delivering workshops and content on pregnancy, infant care, and parenting to drive top-of-funnel engagement.
Matercell firmographics
Firmographics- Name
- Matercell
- Legal name
- MaterCell S.A.
- Website
- https://matercell.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- MaterCell is Argentina's first private umbilical cord blood and tissue stem cell bank, founded in 2009 and based in Buenos Aires. It serves expectant families with blood and tissue cryopreservation under two plans, recurring annual storage fees, and ISO 9001/AABB-certified quality standards.
- Ownership category
- akta.pro rank
Matercell industry classification
Industry- Product category
- Stem Cell Banking Services
- NAICS
- Blood and Organ Banks (621991), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
Keywords
Where Matercell is headquartered
LocationHeadquarters
- HQ city
- Buenos Aires
- HQ country
- Argentina
- HQ region
- Latin America
Offices1 record
Markets served
Matercell business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Stem Cell Banking Services (Initial Collection and Processing): One-time fees for collection, processing, and initial cryopreservation of umbilical cord blood and/or tissue stem cells. Services include kit delivery, sample collection at birth, laboratory processing, and initial storage. Two tiers available: Plan 2 (Doble Cuidado) and Plan 3 (Máxima Protección).
- Annual Storage/Maintenance Fees: Recurring annual fees for ongoing cryopreservation and storage of stem cell samples. The annual fee covers maintenance, viability monitoring, and sample security. Debit automatic payment option with 10% discount. Billing occurs annually around the child's birth month.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Plan 2: Doble Cuidado - Blood + Tissue Storage |
| Subscription | Annual | Plan 3: Máxima Protección - Blood + Tissue + Cell Expansion |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels8 records
Matercell product offering
Product offeringCore offering
MaterCell provides umbilical cord blood and tissue stem cell collection, laboratory processing, and long-term cryopreservation at -196°C in liquid nitrogen for Argentine families expecting newborns. It sells this through two service tiers: Plan 2 Doble Cuidado (blood + tissue storage) and Plan 3 Máxima Protección (blood + tissue + mesenchymal cell expansion), each requiring an annual maintenance fee. Sample collection occurs at partner hospitals and maternity centers, with processing and storage performed at the company's own laboratory under ISO 9001:2015 and AABB-aligned quality standards.
Product overview
MaterCell is a private umbilical cord blood and tissue stem cell bank in Argentina, the first private bank in the country to offer both hematopoietic (blood) and mesenchymal (tissue) stem cell preservation for family use. The company operates two service plans: Plan 2. Doble Cuidado (Blood + Umbilical Cord Tissue) as the standard tier, and Plan 3. Máxima Protección (Blood + Tissue + Mesenchymal Cell Expansion) as the premium tier with immediate cell availability. All plans include annual cryopreservation storage at -196°C in liquid nitrogen, quality reports, and professional medical advisory services. The complementary MaterCare platform provides on-demand educational workshops for families on parenting, pregnancy, and child health topics.
Differentiator
Problem solved
Functional benefit
Products and services
- Plan 2. Doble Cuidado Standard tier stem cell banking service for Argentine expectant families that includes collection, laboratory processing, and long-term cryopreservation of both umbilical cord blood (hematopoietic stem cells) and umbilical cord tissue (mesenchymal stem cells), with the tissue available for future expansion. Annual maintenance fee applies.
- Plan 3. Máxima Protección Premium stem cell banking tier for Argentine expectant families that includes umbilical cord blood cryopreservation, umbilical cord tissue cryopreservation, and pre-expansion of mesenchymal stem cells so that cells are immediately available for treatment. Annual maintenance fee applies.
- MaterCare Educational and wellness platform offered by MaterCell to families, providing on-demand workshops and content led by healthcare professionals on topics such as pregnancy, newborn care, breastfeeding, parenting, nutrition, and child health, with 50+ workshops available via the MaterCare OnDemand channel.
Quantifiable outcome
- 1 in 3 people could benefit from stem cell preservation over their lifetime (Cord Blood Awareness)
- +1 more outcomes
Companies that use Matercell
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Matercell technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Matercell partnerships and signals
Strategic signalPartnerships
27 partnerships are on record, tiered core and minor.
- Sanatorio OtamendicorePartnership providing stem cell banking services to patients at Sanatorio Otamendi, one of Argentina's leading private hospitals. Special benefit plans available for Sanatorio Otamendi patients.
- MedifécoreHealth insurance company partnership offering MaterCell services to Medifé members with plans Bronze, Silver, Gold, and Platinum. Reduced initial payment and special benefits for associated members.
- OsdePYMcoreHealth insurance company partnership offering MaterCell services and benefits to OsdePYM members.
- Yo Nací en Mater DeicorePartnership with Mater Dei hospital's program for families who gave birth at the hospital, offering discounts and benefits for stem cell banking services.
- Sanatorio ArgentinominorHealthcare institution partner listed among companies accompanying MaterCell services.
- Hospital Italiano Regional del SurminorHealthcare institution partner in southern region, listed among companies accompanying MaterCell services.
- AccenturecoreCorporate partnership offering stem cell banking benefits to Accenture employees in Argentina.
- GlobantcoreCorporate partnership offering stem cell banking benefits to Globant employees in Argentina.
- Cervecería y Maltería QuilmescoreCorporate partnership offering stem cell banking benefits to Cervecería y Maltería Quilmes employees.
- AirLiquidecoreTechnology provider for cryopreservation systems. MaterCell uses AirLiquide-developed cryopreservation processes with remote monitoring and digital automation for secure sample storage.
- Banco GaliciaminorBanking partner for payment processing. Customers can make deposits or transfers to Banco Galicia accounts (CTA CTE EN PESOS 1430-0314-1, CBU provided) for service payments.
- Centro UGminorHealthcare institution partner listed among companies accompanying MaterCell services.
- MedigenminorHealthcare institution partner listed among companies accompanying MaterCell services.
- CIDEMminorHealthcare institution partner listed among companies accompanying MaterCell services.
- Centro Médico EcheverríaminorHealthcare institution partner listed among companies accompanying MaterCell services.
- Centro Médico Fundación UrkupiñaminorHealthcare institution partner listed among companies accompanying MaterCell services.
- Instituto Médico de la MujerminorHealthcare institution partner listed among companies accompanying MaterCell services.
- MaslowminorHealthcare institution partner listed among companies accompanying MaterCell services.
- MaterminorHealthcare institution partner listed among companies accompanying MaterCell services.
- KynetminorHealthcare institution partner listed among companies accompanying MaterCell services.
- MAICE | Maternity Integral CenterminorHealthcare institution partner listed among companies accompanying MaterCell services.
- MedicusminorHealth insurance company partner listed among companies accompanying MaterCell services.
- Life SegurosminorInsurance company partner listed among companies accompanying MaterCell services.
- CTNminorHealthcare network partner listed among companies accompanying MaterCell services.
- VistageminorExecutive coaching company partner listed among companies accompanying MaterCell services.
- MedelaminorBreast pump brand partner featured on MaterCare platform for breastfeeding support content.
- TwistshakeminorBaby product brand partner featured on MaterCare platform.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Matercell competitors and assessment
Company assessmentDirect peers
- Cryo-Cell International: US-listed private cord blood and tissue bank offering collection, processing, and long-term cryopreservation for family use. Closest global comparable to MaterCell by service mix (blood + tissue storage) and customer profile (expectant families).
- ViaCord (Revvity): US-based cord blood and cord tissue bank owned by Revvity (formerly PerkinElmer), serving expectant families with similar storage and processing services. Comparable business model with tiered plans and recurring storage fees.
- Cord Blood Registry (CBR): One of the largest US private cord blood banks, offering collection, processing, and long-term storage of newborn stem cells. Directly comparable in service offering, family-use positioning, and recurring revenue model.
- Cells4Life: UK-based cord blood and tissue bank with multi-site processing capabilities and a strong emphasis on cord tissue and cell expansion services. Comparable premium-tier offering (tissue + expansion) overlapping MaterCell's Plan 3.
- Smart Cells International: UK private cord blood stem cell bank shipping collection kits globally. Comparable international courier-based collection model relevant to MaterCell's potential cross-border expansion and competitive threats.
- FamilyCord: US private cord blood and cord tissue bank offering collection kits and long-term storage. Similar consumer-facing proposition and tiered service plans as MaterCell.
Regional players
- China Cord Blood Corporation: Largest operator of cord blood banks in China, focused on storage for family and potential public use. Comparable private-storage model with regional scale, useful as a benchmark for how stem cell banking scales in non-US markets.
- Hemocord: Brazilian private cord blood bank offering collection, processing, and cryopreservation for family use. Closest Latin American peer to MaterCell, serving a comparable customer base in a neighboring market with similar emerging-market dynamics.
Emerging players
- Crioestaminal: Portuguese/Spanish private cord blood and tissue bank with ISO and AABB-aligned quality standards. Comparable in quality certifications and European/Iberian market positioning; relevant peer for benchmarking premium-tier tissue services.
Broad incumbents
- New York Blood Center (National Cord Blood Program): Large nonprofit blood center operating a public cord blood bank and broader transfusion medicine services. Useful as a benchmark for regulatory and quality benchmarks (e.g., FACT/NETCORD) that MaterCell's ISO/AABB-aligned operation is measured against.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Matercell social profiles
Digital presenceMatercell compliance and trust
Trust signalCompliance1 record
Matercell financial estimates
Financial estimateRevenue estimate
Valuation estimate
Matercell leadership team
Management profileNumber of profiles
Profiles4 records
Matercell funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Matercell M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Matercell
What does Matercell do?
MaterCell provides umbilical cord blood and tissue stem cell collection, laboratory processing, and long-term cryopreservation at -196°C in liquid nitrogen for Argentine families expecting newborns. It sells this through two service tiers: Plan 2 Doble Cuidado (blood + tissue storage) and Plan 3 Máxima Protección (blood + tissue + mesenchymal cell expansion), each requiring an annual maintenance fee. Sample collection occurs at partner hospitals and maternity centers, with processing and storage performed at the company's own laboratory under ISO 9001:2015 and AABB-aligned quality standards.
Is Matercell a public or private company?
Matercell is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Matercell founded?
Matercell was founded in 2009. It employs 51 to 100 people.
Where is Matercell based?
Matercell is headquartered in Buenos Aires, Argentina, in the Latin America region.
How does Matercell make money?
Two revenue lines are on record. Stem Cell Banking Services (Initial Collection and Processing) is the primary driver. The others are annual Storage/Maintenance Fees.
Who are Matercell's main competitors?
Direct peers on record are Cryo-Cell International, ViaCord (Revvity), Cord Blood Registry (CBR), Cells4Life, Smart Cells International and FamilyCord. Regional players are China Cord Blood Corporation and Hemocord. Crioestaminal is listed as an emerging player. New York Blood Center (National Cord Blood Program) is listed as a broad incumbent.
Does Matercell have an API?
No public API is recorded for Matercell.
What industry is Matercell in?
Matercell's product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 8071.